After establishing the critical role of the MLX-SLC7A11 axis in metabolic reprogramming of osteosarcoma cells, we hypothesized that inhibiting this axis could disrupt the redox balance and cause ferroptosis, resulting in defects in the aggressive phenotypes of osteosarcoma. The gene discussed is SLC7A11; the disease is osteosarcoma.